Research and Markets: Pharmaceutical Partnering Yearbook 2013

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/fd2rzx/pharmaceutical) has announced the addition of the "Pharmaceutical Partnering Yearbook 2013" report to their offering.

Provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2012

Key benefits

Pharmaceutical Partnering Yearbook 2013 series provides the reader with the following key benefits:

- In-depth understanding of recent dealmaking trends during 2012

- Comprehensive access to all deals entered into by the world's biopharma companies during 2012

- Detailed access to actual partnership deals and contracts entered into by the leading fifty bigpharma companies

- Understand the key deal terms companies have agreed in previous deals

- Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

Pharmaceutical Partnering Yearbook 2013 series is intended to provide the reader with an in-depth understanding and access to parthering and M&A trends and structure of deals entered into by leading companies worldwide.

Pharmaceutical Partnering Yearbook 2013 includes:

- Trends in dealmaking in the biopharma industry during 2012

- Comprehensive directory of partnering deals in 2012

- Links to online access to all deals and alliances

- The leading partnering deals by value in 2012

- Most active partnering dealmakers during 2012

In Pharmaceutical Partnering Yearbook 2012 series the partnering and M&A deals are listed by:

- Company A-Z

- Headline value

- Stage of development at signing

- Deal component type

- Therapy area

- Technology type

Each deal title links via Weblink to an online version of the deal record at Current Agreements and where available, the contract document, providing easy access to each contract document on demand.

This report is compiled on-demand

On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data.

Key Topics Covered:

Executive Summary

Chapter 1 - Trends in dealmaking during 2012

Chapter 2 - Leading deals during 2012

Chapter 3 - Bigpharma deals during 2012

Chapter 4 - Partnering deals directory 2012

Table of figures

For more information visit http://www.researchandmarkets.com/research/fd2rzx/pharmaceutical